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Background: It is generally believed that there are many natural sources of as yet unknown bioactive compounds
with a high biotechnological potential. However, the common method based on the use of cell extracts in the
preliminary screening for particular molecules or activities is problematic as amounts of obtained compounds may
be low, and such experiments are hardly reproducible. Therefore, the aim of this work was to test whether a novel
strategy to search for previously unknown biological activities can be efficient. This strategy is based on
construction of metagenomic libraries and employment of Escherichia coli strains as cell factories producing
compounds of properties potentially useful in biotechnology.
Results: Three cyanobacterial metagenomic libraries were constructed in the fosmid system. The libraries were
screened for various biological activities. Extracts from selected E. coli clones bearing constructs with fragments of
cyanobacterial genomes revealed antimicrobial or anticancer activities. Interestingly, stimulation of growth of host
bacteria bearing particular plasmids with certain cyanobacterial genes was detected, suggesting a potential
possibility for improvement of E. coli cultivation during biotechnological production. The most interesting plasmids
were sequenced, and putative mechanisms of biological effects caused by cyanobacterial gene products are
discussed.
Conclusions: The strategy of exploring cyanobacteria as sources of bioactive compounds, based on E. coli cell
factories producing compounds due to expression of genes from metagenomic libraries, appears to be effective.
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It is generally believed that organisms, mainly algae and
higher plants, living in their natural habitats, are sources
of many unknown compounds which can be of high bio-
technological and pharmacological potential. However,
commonly used methods of preliminary screening for in-
teresting biological activities in tested organisms, based on
analysis of cell or tissue extracts, are problematic due to
their limited efficiency and reproducibility (see next para-
graphs for details).* Correspondence: grzegorz.wegrzyn@biol.ug.edu.pl
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unless otherwise stated.Cyanobacteria, called also blue-green algae, appear to be
potentially rich sources of bioactive compounds [1]. They
are photosynthesizing prokaryotic organisms, occupying
marine, freshwater and terrestrial habitats, and belong to
the oldest biological groups on Earth. It appears that mar-
ine cyanobacteria may be particularly rich in biotechno-
logically and pharmacologically useful molecules [2],
however, it is considered that they are underexploited in
this matter [3]. On the other hand, in recent years, an
interest in bioactive compounds derived from these mi-
croorganisms increased significantly [4]. This is perhaps,
at least in part, due to publication of papers reporting iso-
lation of various compounds from cyanobacteria, includ-
ing those possessing antiviral, antibacterial, antifungal and
anticancer activities (summarized in ref. [5]).entral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Cyanobacterial metagenomic libraries
constructed in this work
Library Source of DNA Number of
obtained clonesa
Library 1 Bloom of Nodularia sp.; Gdańsk Bay,
Baltic Sea (Poland), June 2009
1,806
Library 2 Bloom of Nodularia sp. and
Aphanizomenon flos-aquae; Gdańsk Bay,
Baltic Sea (Poland), May 2011
2,234
Library 3 Mixed cultures of: Microcystis aeruginosa
CCNP 1101, Microcystis aeruginosa CCNP
1102, Microcystis aeruginosa CCNP 1103,
Anabaena sp. CCNP 1406, Synechocystis
salina CCNP 1104
~30,000
aNumber of clones appearing after infection of E. coli host cells with 1/10 of
volume of fosmid lysate obtained during the library construction.
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ther easy nor simple. Despite evident successes in the
use of these organisms in production of novel bio-fuels
[6,7], previous studies on identification of bioactive
compounds in blue-green algae concentrated mostly on
characterization of their cellular extracts. Such a strat-
egy was effective in detection of secondary metabolites
with interesting properties [8,9]. However, the use of ex-
tracts has an important drawback, namely, production
of certain compounds may depend on specific physio-
logical conditions, thus, it may be difficult to repeat the
exact conditions under which particular compounds
were found in extracts. Moreover, efficiency of extrac-
tion of particular compounds from samples withdrawn
from a natural habitat may be of low efficiency, and
such experiments can be hardly reproducible due to
changing environmental conditions. Therefore, a need
for construction of cyanobacterial metagenomic librar-
ies to discover previously unknown functional genes in-
volved in biosynthesis of biotechnologically relevant
compounds has been postulated [5]. Nevertheless, des-
pite determination of full nucleotide sequences of ge-
nomes of many cynaobacterial strains [10], the use of
genomic and metagenomic approaches in searching for
bioactive compounds derived from cyanobacteria was not
extensive. In fact, most such methods were employed to
detect genes coding for enzymes revealing particular,
desired features [11,12], rather than to detect novel bio-
logical activities.
The aim of this work was to test whether a novel strat-
egy, based on the use fosmid metagenomic libraries to
search for biological activities appearing in Escherichia
coli host cells bearing plasmids with fragments of
cyanobacterial genomes, can be effective in detecting
biotechnologically interesting features. If yes, this strat-
egy might be used in subsequent works for isolation and
characterization of compounds revealing particular ac-
tivities, which would be significantly facilitated by avail-
ability of specific clones, eliminating potential problems
with the amount of tested compounds and reproducibil-
ity of results. Efficient construction of the libraries was
possible, between others, due to employment of a re-
cently optimized method for isolation and purification
of genomic DNA from filamentous cyanobacteria, suit-
able for construction of genomic libraries [13]. Such
procedures are challenging due to production by cyano-
bacteria of large amounts of cellulose, pectins, murein
and xylose, which are components of the cell wall.
Moreover, these microorganisms synthesize and excrete
complex polysaccharides and proteins which form mu-
cous envelope and the protein S layer [14,15]. All these
compounds interfere with commonly used procedures
of DNA isolation and purification. The improved
method allowed us to overcome most of these problems[13] which facilitated efficient construction of cyanobac-
terial metagenomic libraries and their use in searching
for biological activities.
Results and discussion
Construction of cyanobacterial metagenomic libraries
Three fosmid-based libraries of cyanobacterial metagen-
omes have been constructed. They were prepared using
genomic DNA, isolated according to previously published
procedure [13], derived from: (a) a bloom of Nodularia sp.
which occurred in Gdańsk Bay, Baltic Sea (Poland) in June
2009; library 1; (b) a bloom of Nodularia sp. and Aphani-
zomenon flos-aquae which occurred in Gdańsk Bay, Baltic
Sea (Poland) in May 2011; library 2; and (c) cultures of 5
marine cyanobacteria, isolated from Baltic Sea (deposited
in Culture Collection of Northern Poland, CCNP, at Uni-
versity of Gdańsk, Poland) and cultured in laboratory:
Microcystis aeruginosa CCNP 1101, Microcystis aerugi-
nosa CCNP 1102, Microcystis aeruginosa CCNP 1103,
Anabaena sp. CCNP 1406, Synechocystis salina CCNP
1104; library 3. Characteristics of these libraries are pro-
vided in Table 1. Considering an average sizes of cyano-
bacterial genome (reported to be between 1.44 and
9.05 Mb [10]), it was calculated that about 600 clones in
the fosmid-based library (with average size of the insert of
40 kb) should cover efficiently a whole single genome.
The obtained clones in each library were, therefore, suffi-
cient to cover at least several cyanobacterial genomes.
As indicated above, two libraries (no. 1 and 2) were
constructed with the use of DNA isolated from environ-
mental samples of biological material, whereas library 3
contained DNA isolated from a mixture of 5 strains (to
increase variability of the library) of cyanobacteria cul-
tured in laboratory after their isolation from a natural
habitat. As shown in Table 1, cultivation of cyanobac-
teria under laboratory conditions enhanced efficiency of
metagenomic library construction (~30.000 clones vs.
~2.000 clones). We suggest that this might arise from











Figure 1 Growth of E. coli cells bearing different clones from
libraries. The growth (37°C, LB medium) of bacteria bearing a
control clone 105–2 (diamonds), or clone 123–3 (squares) or 129–3
(triangles) from the cyanobacterial metagenomic library was
monitored. Mean values from 3 independent experiments are
shown with error bars indicating SD. Calculated generation times at
the mid-exponential phase of growth were 36 min for bacteria
bearing 105–2, 28 min for bacteria bearing 123–3, and 28 min for
bacterial bearing 129–3.
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purification, and/or cloning procedures.
Inhibition of bacterial growth by extracts from library
clones
In preliminary tests, extracts from 200 clones, randomly
taken from constructed libraries, were prepared. These ex-
tracts were assessed for their effects on growth of various
bacteria (strains of Serratia marcescens, Pseudomonas aer-
uginosa, Staphylococcus aureus, Micrococcus luteus, E.coli
K-12, and E. coli O157:H7 were employed) in 96-well
plates. More detailed analyses were performed in liquid
bacterial cultures. It was found that 1% extract from host
bacteria bearing the clone 123–2 inhibited growth of S.
marcescens and E.coli B by 45% and 40%, respectively,
as assessed by measurement of optical density of bacterial
cultures. Although this inhibition of growth was not
dramatic, it is important to note that concentration of the
extract was relatively low (1%). Thus, it is likely that iden-
tification of the inhibitory agent should allow to clone ap-
propriate gene(s) in an expression vector, its production in
large amounts, and its potential use to achieve significant
inhibition of bacterial growth.
Stimulation of host bacterium growth by the presence of
specific clones from the libraries
Although for medical application it is useful to identify
antibacterial activities, for biotechnological purposes,
it is often desirable to stimulate growth of bacteria
which are employed to express recombinant genes and
synthesize particular products. Therefore, we have also
tested effects of the presence of clones from the libraries
on growth of host E. coli cells. Since it is known that the
presence of plasmids, especially relatively large con-
structs, may influence bacterial metabolism, physiology
and growth [16,17], in control experiments, a strain
bearing a plasmid analogous to those containing frag-
ments of cyanobacterial genomes, but carrying a frag-
ment of E. coli genome (the 105–2 clone), was used.
Perhaps surprisingly, it was found that in the presence
of clone 123–3 or 129–3, the growth of E. coli host was
stimulated rather than inhibited (Figure 1). Generation
time at mid-exponential phase of growth was 36 min for
the control strain, while it was calculated as 28 min for
cells bearing either 123–3 or 129–3 clone. This indicates
that expression of some cyanobacterial genes may en-
hance growth of E. coli cells which may be potentially use-
ful in construction of new host strains to be used as
microbial cell factories for biotechnological production of
certain compounds.
Anticancer activity of extracts from libraries’ clones
To test anticancer activity, effects of 370 clone extracts,
prepared as described above (for testing inhibition ofbacterial growth), on viability of cancer cells (the MCF-7
cells line) and normal human fibroblast cells (the HDFa
cell line), were assessed. After preliminary screening,
and following more detailed analyses, it was found that
extract from clone 123–3 significantly decreased viability
of cancer cells in a dose–response manner (Figure 2).
Importantly, effects of this extract on normal human
cells were negligible (Figure 2). These results suggest
that expression of some cyanobacterial genes in E. coli
causes production of anticancer compound(s), while
having no significant effects on viability of normal hu-
man cells.
Analysis of sequences of selected clones
Since some clones from cyanobacterial metagenomic li-
braries revealed interesting properties, nucleotide se-
quences of inserts of selected constructs were determined.
Following clones were chosen: 123–2 (extract from bac-

























Figure 2 Effects of extracts from library clones on viability of
human cells. Viability of wild-type HDFa (triangles) and cancer MCF-7
(squares) cells was assessed in media supplemented with various
amounts of the extract from bacteria bearing the 123–3 clone. Mean
values from 3 independent experiments are shown with error bars
indicating SD. Statistically significant differences (p < 0.05 in the t-test)
between two cell lines are indicated by asterisks. Viability of MCF-7 cells
in the presence of the extract was significantly (p < 0.05) decreased
relative to cultures without the extract at the same concentrations, thus
no additional symbols are shown. The presence of the extract did not
cause any significant decrease in viability of HDFa cells at all tested
concentrations (p > 0.05).
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bearing this clone caused decreased viability of cancer
cells, but not normal human cells, and growth of bacteria
bearing this clone was stimulated), and 129–3 (growth of
bacteria bearing this clone was stimulated).
Nucleotide sequences of the selected clones were de-
termined, deposited in GenBank (accession numbers:
KJ769136, KJ769135, KJ769134 for 123–2, 123–3, 129–
3, respectively), and analysis of open reading frames in-
cluded in the fragments of cyanobacterial genomes was
performed. Results of analyses of selected genes, dis-
cussed below, are presented in Tables 2, 3 and 4 (for
123–2, 123–3, and 129–3, respectively).
The fragment included in the 123–2 clone contains
several ORFs coding for putative enzymes (Table 2). Al-
though no obvious candidate for a protein which, when
liberated from cells, might inhibit bacterial growth was
found, some enzymes might influence transport ofparticular compounds (putative products of wcaG, tolQ,
tolR, rhaT genes), peptidoglycan structure (putative
product of the pasL gene) or outer membrane function
(putative product of the opaP gene). On the other hand,
it might be not an enzyme but a product of its reaction
that could negatively affect S. marcescens and E.coli B
growth when present in cell extract. Definitely, in order
to indentify compound(s) responsible for bacterial growth
inhibition, it would be necessary to clone smaller frag-
ments of the 123–2 construct, determine gene(s) respon-
sible for specific effects, and investigate the mechanism of
inhibition. This, however, was not the aim of this study
which focused on testing whether cyanobacterial metage-
nomic libraries can be successfully employed in searching
for various biological activities.
The clone 123–3 (Table 3) appeared the most interest-
ing one among all tested in this study. First, extract from
bacteria bearing this clone caused decreased viability of
cancer cells, while having little effect on normal human
cells. Second, growth of bacteria bearing this clone was
stimulated. The latter effect might be potentially caused
by activities of putative proteins encoded in the tested
genome fragment, and involved in biosynthesis of pro-
teins (gatA, gatC, rpmG ) and nucleotides (pyrC). More-
over, the transport of amino acids and carbohydrates
from the medium could be intensified by metA, and
gckA genes’ products. Stimulation of protein and nucleic
acid syntheses might likely enhance growth rate of
host bacteria. Nevertheless, actual mechanism of this
phenomenon remains to be elucidated. Even more dif-
ficult is to predict the cause of anticancer action of extract
from bacteria bearing the 123–3 clone. Although it seems
more likely that product(s) of reaction(s) of enzyme(s)
encoded in the insert of this clone may affect viability of
cancer, but not normal, cells, one cannot exclude a possi-
bility that some enzymes (like products of phpP and/or
medH genes) themselves might interfere with functions of
cells of the MCF-7 line.
Although stimulatory effects of the presence of clones
123–3 and 129–3 on growth of host cells were similar,
two analyzed DNA fragments contain different ORFs.
Nevertheless, DNA of 129–3 codes for several putative
proteins involved in pathways of biosyntheses of proteins
and lipids (thrC, rimL, phaS, lpxB, cfaS, homD, metC)
and theirs transport (arnT, hisJ). Therefore, one may
speculate that stimulation of anabolic processes might
positively affect growth rate of E. coli host cells, which can
have a potential impact on biotechnological production.
Conclusions
Construction of cyanobacterial metagenomic libraries, and
expression of genes from particular clones in E. coli, re-
sulted in detection of antibacterial, anticancer, and bacter-
ial growth stimulatory activities in extracts of host cells, as





Significant similarity (%) to known
gene from indicated organism
Description
1381-497 wcaG Not found COG0451 Nucleoside-diphosphate-sugar epimerases [cell envelope biogenesis,
outer membrane/carbohydrate transport and metabolism]
4578-5294 tolQ 75% Sinorhizobium fredii NGR234 COG0811 Biopolymer transport proteins [intracellular trafficking and secretion]
5304-5756 tolR 75% Sinorhizobium fredii NGR234 TIGR02801 biopolymer transport protein, TolR
8452-8955 pasL 74% Sinorhizobium meliloti 2011 PRK10802 Peptidoglycan-associated lipoprotein
15265-16134 opaP 67% Sinorhizobium meliloti 2011 COG3637 Opacity protein and related surface antigens [cell envelope
biogenesis, outer membrane]
24299-23364 rhaT 67% Sinorhizobium fredii NGR234 COG0697 Permeases of the drug/metabolite transporter (DMT) superfamily
[carbohydrate transport and metabolism/amino acid transport and metabolism]
Selected genes located in this DNA fragment are described.
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characterization of particular active compounds require
further analyzes, and specific mechanisms leading to ob-
served effects remain to be elucidated, but one should
note that they were not aims of the current work. The
presented results provide a proof of concept that the strat-
egy of searching for various bioactive compounds in




Following cyanobacteria were employed: Nodularia sp.
isolated from a bloom which occurred in Gdańsk Bay
(Baltic Sea, Poland) in June 2009, Nodularia sp. and
Aphanizomenon flos-aquae isolated from a bloom which
occurred in Gdańsk Bay (Baltic Sea, Poland) in May
2011, and following 5 strains isolated from Baltic
Sea and deposited in Culture Collection of Northern
Poland, CCNP, at University of Gdańsk (Poland):
Microcystis aeruginosa CCNP 1101, Microcystis aeru-
ginosa CCNP 1102, Microcystis aeruginosa CCNPTable 3 Results of analysis of DNA sequence of the insert in c
ORF position
in the clone
Putative gene Significant similarity (%) to known
gene from indicated organism
Desc
401-1672 gckA Not found COG2
2611-1691 phpP Not found PLN0
4201-2720 gatA 76% Rhizobium sp. strain NT-26 COG0
amid
4976-4689 gatC 76% Rhizobium sp. strain NT-26 COG0
ribos
5828-5118 medH 75% Agrobacterium vitis S4 PRK0
11125-12420 pyrC 67% Rhizobium sp. strain NT-26 cd01
rever
react
20911-22095 matA 71% Rhizobium leguminosarum bv.
trifolii CB782
Multi
22188-22355 rpmG 71% Rhizobium sp. str. NT-26 PRK0
Selected genes located in this DNA fragment are described.1103, Anabaena sp. CCNP 1406, and Synechocystis
salina CCNP 1104.
Following bacterial strains were employed for testing
antibacterial activities of extracts from libraries’ clones: Ser-
ratia marcescens, Pseudomonas aeruginosa, Staphylococcus
aureus, Micrococcus luteus, Escherichia coli B, Escherichia
coli O157:H7. Strains S. aureus DMB-pR1-20 and P. aerugi-
nosa DMB-pR1-23 were isolated in the Medical University
Hospital in Gdańsk, and identified with the use of VITEK
Legacy (bioMérieux). Strain M. luteus DMB-pR1-1, isolated
from the human throat [18], and strain S. marcescens
DMB-pR1-2 were kindly provided by Prof. T. Kaczorowski,
Department of Microbiology, University of Gdansk; the
identification of strain S. marcescens DMB-pR1-2 was con-
firmed by Elżbieta Mączak (University of Gdańsk). Clinical
strain E. coli O157:H7 was obtained from the Cincinnati
Children’s Hospital Medical Center [19].
Human cell lines
Human Dermal Fibroblast adult line (HDFa; Cascade Bi-
ologics, Portland, OR, USA) was employed. The human
breast adenocarcinoma (MCF-7) cell line was obtainedlone 123–3
ription
379 Putative glycerate kinase [carbohydrate transport and metabolism]
2645 phosphoglycolate phosphatase
154 Asp-tRNAAsn/Glu-tRNAGln amidotransferase A subunit and related
ases [translation, ribosomal structure and biogenesis]
721 Asp-tRNAAsn/Glu-tRNAGln amidotransferase C subunit [Translation,
omal structure and biogenesis]
0685 metal-dependent hydrolase; Provisional
317 Dihydroorotase (DHOase), subgroup IIa; DHOases catalyze the
sible interconversion of carbamoyl aspartate to dihydroorotate, a key
ion in pyrimidine biosynthesis
drug ABC transporter ATPase/protein_id = “AHG44931.1
0595 50S ribosomal subunit protein L33
Table 4 Results of analysis of DNA sequence of the insert in clone 129–3
ORF position
in the clone
Putative gene Significant similarity (%) to known
gene from indicated organism
Description
1885-3162 thrC 73% Starkeya novella DSM 506 COG0498 Threonine synthase [amino acid transport and metabolism]
4778-5017 rimL 70% Polymorphum gilvum SL003B-26A1 COG1670 Acetyltransferases, including N-acetylases of ribosomal proteins
[Ttanslation, ribosomal structure and biogenesis]
10222-8198 phaS 74% Polymorphum gilvum SL003B-26A1 TIGR01838 poly (R)-hydroxyalkanoic acid synthase, class I [fatty acid and
phospholipid metabolism, Biosynthesis]
11838-13154 homD 69% Polymorphum gilvum SL003B-26A1 PRK06349 Homoserine dehydrogenase [synthesis of Met, Thr, Ile from Asp]
19761-21452 arnT 78% Starkeya novella DSM 506 COG1807 4-amino-4-deoxy-L-arabinose transferase and related
glycosyltransferases of PMT family [amino acids and vitamins transport]
22371-22703 lpxB 76% Mesorhizobium loti MAFF303099 PRK01021 lipid-A-disaccharide synthase
23930-22725 metC 65% Starkeya novella DSM 506 PRK05967 cystathionine beta-lyase [methionine and cysteine metabolism]
24090-25163 hisJ 67% Starkeya novella DSM 506 COG0834 ABC-type amino acid transport/signal transduction systems,
periplasmic component/domain [amino acid transport and metabolism/
signal transduction mechanisms]
29290-27989 cfaS 70% Mesorhizobium opportunistum
WSM2075
COG2230 Cyclopropane fatty acid synthase and related methyltransferases
[cell envelope biogenesis, outer membrane]
Selected genes located in this DNA fragment are described.
Felczykowska et al. Microbial Cell Factories 2014, 13:105 Page 6 of 7
http://www.microbialcellfactories.com/content/13/1/105from the Department of Microbiology, Tumor and Cell
Biology, Karolinska Institute, Sweden. These cell lines
were used in experiments testing effects of extracts from
clones of libraries on viability of human cells.
Construction of cyanobacterial metagenomic libraries
Fosmid metagenomic libraries were constructed with the
use of the CopyControl Fosmid Library Production Kit
with pCC2FOS Vector (purchased from Epicentre Bio-
technologies), according to manufacturer’s instructions.
Cyanobacterial genomic DNA was isolated and purified as
described previously [13], and 20 μg of DNA from each
isolation experiment were used for library construction.
The final product of each construction procedure was
1 ml of phage lysate which was then used to infect E. coli
T1R host strain (provided in CopyControl Fosmid Library
Production Kit). Number of obtained clones in each ex-
periment is provided in Table 1. Routinely, 0.1 ml of the
lysate was used, and the rest (0.9 ml) is being stored for
potential further use. For control experiments, a clone
bearing the 41,285 bp fragment of E. coli genome, encom-
passing the region between abc2T and pdpN genes, was
constructed and named 105–2.
Preparation of extracts from library clones
Bacterial (E. coli) clones from a gene library were cul-
tured in 10 ml of LB medium (Sigma) supplemented
with Fosmid Library AutoInduction Solution (Epicentre
Biotechnologies; 1:500, v/v) at 37°C for 16 h at 150 rpm.
Then, the cultures were centrifuged (4,000 rpm, 10 min),
and the pellets were suspended in 2 ml of 0.01 M Tris–
HCl buffer pH 7.0 (Sigma). The mixtures were sonicated
(pulsar = 20% of maximal amplitude, 6 min) and filtered
with the use of CA membrane filters (Corning).Assessment of antibacterial activities of extracts
Preliminary tests were performed in 96-well plates. Bacter-
ial strains were precultured in LB medium (Sigma) at 37°C
for 16 h at 150 rpm. Suspensions of cultures were pre-
pared to obtain a final inoculum of 2 × 105 cfu/ml in each
assay. The cultures were incubated in 96-well plate in the
presence of gene library clone extracts at concentrations
between 0.5 and 25% (v/v) for 24 h. Then, optical density
was measured at 570 nm. Data were obtained from at least
three independent experiments.
After preliminary screening, more detailed assays were
performed in flask cultures. Bacterial strains were pre-
cultured and inoculated as described above. 30 ml of
cultures in LB medium were incubated at 37°C, at
150 rpm, in the presence of gene library clone extracts
at final concentration 1% (v/v) for 24 h. Optical density
was measured at 600 nm in time intervals for 24 h. Data
were obtained from at least three independent experiments.
Estimation of effects of library clones on host cell growth
E. coli T1R cells bearing particular library clone were grown
as described in the preceding section. Number of bacteria
per ml of culture was determined at indicated times by
measurement of A600. Generation time of each culture was
calculated from results obtained during mid-exponential
phase of growth.
Determination of human cell viability
MCF-7 cells were maintained in RPMI 1640 (Sigma)
medium supplemented with 10% (v/v) fetal bovine serum
and antibiotics (Sigma). HDFa cells were maintained in
DMEM medium (Sigma) supplemented with 10% (v/v) fetal
bovine serum (Sigma), antibiotics and 4 mM L-glutamine
(Sigma).
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method [20]. Briefly, cells were seeded at density of 4 ×
103 per well of 96-well plate, and allowed to attach over-
night. The medium was replaced with a fresh one sup-
plemented with 1, 5, 10, 15, or 20% (v/v) of library clone
extract, and the incubation was continued for 24 h.
Then, 25 μl of MTT solution (4 mg/ml; Sigma) was
added to each well. After 3 h incubation, the medium
was removed, and 100 μl of DMSO per well was added.
Absorbance was measured at 570 nm (with reference
wavelength 660 nm). Data were obtained from at least
three independent experiments.
DNA sequence determination and analysis
DNA sequences of selected clones were determined by
commercial sequencing (Genomed S.A.). Sequences were
analyzed using the BLAST software. ORFs were compared
and analyzed using Clone Manager 7 (Sci-Ed Software).
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